Patents by Inventor Christine Schmitt

Christine Schmitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHEMICAL MECHANICAL POLISHING (CMP) COMPOSITION COMPRISING A SPECIFIC HETEROPOLYACID
    Publication number: 20130189842
    Abstract: A chemical mechanical polishing (CMP) composition comprising a specific heteropolyacid Abstract A chemical-mechanical polishing (CMP) composition comprising: (A) inorganic particles, organic particles, or a mixture thereof, (B) a heteropolyacid of the formula HaXbPsMOyVzOc wherein X=any cation other than H 8<y<18 8<z<14 56<c<105 a+b=2c?6y?5(3+z) b>0 and a>0 (formula I) or a salt thereof, and, (C) an aqueous medium.
    Type: Application
    Filed: October 4, 2011
    Publication date: July 25, 2013
    Applicant: BASF SE
    Inventors: Christine Schmitt, Andrey Karpov, Frank Rosowski, Mario Brands, Yuzhuo Li
  • USE OF OXAZOLIDINONE-QUINOLINE HYBRID ANTIBIOTICS FOR THE TREATMENT OF ANTHRAX AND OTHER INFECTIONS
    Publication number: 20120322766
    Abstract: The present invention relates to the use of compounds, in which the pharmacophores of quinolone and oxazolidinone are chemically linked together through a linker that is stable under physiological conditions, for the treatment of anthrax and other infections.
    Type: Application
    Filed: August 28, 2012
    Publication date: December 20, 2012
    Applicant: Morphochem Aktiengesellschaft fuer Kombinatorische Chemie
    Inventors: Christian Hubschwerlen, Jean-Luc Specklin, Daniel Baeschlin, Hans Locher, Christine Schmitt
  • Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
    Patent number: 8268812
    Abstract: The present invention relates to the use of compounds, in which the pharmacophores of quinolone and oxazolidinone are chemically linked together through a linker that is stable under physiological conditions, for the treatment of anthrax and other infections.
    Type: Grant
    Filed: January 10, 2011
    Date of Patent: September 18, 2012
    Assignee: Morphochem Aktiengesellschaft fül Kombinatorische Chemie
    Inventors: Christian Hubschwerlen, Jean-Luc Specklin, Daniel Baeschlin, Hans Locher, Christine Schmitt
  • OXAZOLIDINONE-QUINOLONE HYBRID ANTIBIOTICS
    Publication number: 20120142635
    Abstract: The present invention relates to compounds of the Formula (I) that are useful antimicrobial agents and effective against a variety of multi-drug resistant bacteria:
    Type: Application
    Filed: February 8, 2012
    Publication date: June 7, 2012
    Applicant: Morphochem Aktiengesellschaft Fur Kombinatorische Chemie
    Inventors: Christian Hubschwerlen, Jean-Luc Specklin, Daniel Baeschlin, Christine Schmitt, Stefan Müller, Michael W. Cappi
  • USE OF OXAZOLIDINONE-QUINOLINE HYBRID ANTIBIOTICS FOR THE TREATMENT OF ANTHRAX AND OTHER INFECTIONS
    Publication number: 20120135961
    Abstract: The present invention relates to the use of compounds, in which the pharmacophores of quinolone and oxazolidinone are chemically linked together through a linker that is stable under physiological conditions, for the treatment of anthrax and other infections.
    Type: Application
    Filed: January 10, 2011
    Publication date: May 31, 2012
    Applicant: Morphochem Aktiengesellschaft Fur Kombinatorische Chemie
    Inventors: Christian Hubschwerlen, Jean-Luc Specklin, Daniel Baeschlin, Hans Locher, Christine Schmitt
  • Oxazolidinone-quinolone hybrid antibiotics
    Patent number: 8158797
    Abstract: The present invention relates to compounds of the Formula (I) that are useful antimicrobial agents and effective against a variety of multi-drug resistant bacteria.
    Type: Grant
    Filed: December 20, 2004
    Date of Patent: April 17, 2012
    Assignee: Morphochem Aktiengesellschaft fur Kombinatorische Chemie
    Inventors: Christian Hubschwerlen, Jean-Luc Specklin, Daniel Baeschlin, Christine Schmitt, Stefan Müller, Michael W. Cappi
  • Oxazolidinone-Quinolone Hybrid Antibiotics
    Publication number: 20080027040
    Abstract: The present invention relates to compounds of the Formula (I) that are useful antimicrobial agents and effective against a variety of multi-drug resistant bacteria:
    Type: Application
    Filed: December 20, 2004
    Publication date: January 31, 2008
    Applicant: Morphochem Aktiengesellschaft Fur Kombinatorische
    Inventors: Christian Hubschwerlen, Jean-Luc Specklin, Daniel Baeschlin, Christine Schmitt, Stefan Muller, Michael W. Cappi
  • Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
    Publication number: 20070155714
    Abstract: The present invention relates to the use of compounds, in which the pharmacophores of quinolone and oxazolidinone are chemically linked together through a linker that is stable under physiological conditions, for the treatment of anthrax and other infections.
    Type: Application
    Filed: April 6, 2004
    Publication date: July 5, 2007
    Applicant: Morphochem Aktiengesellschaft Fur Kombinatorische Chemie
    Inventors: Christian Hubschwerlen, Jean-Luc Specklin, Daniel Baeschlin, Hans Locher, Christine Schmitt
  • Oxide ceramic superconductive composite member and method for manufacture
    Patent number: 6028036
    Abstract: A superconductive composite member comprises a core of oxide ceramic superconducting material that is disposed in a metal envelope comprising a silver alloy which is hardenable by an oxide dispersion. Preferably, the silver alloy is an alloy of Ag--Mg--Ni, Ag--Mn--Ni or Ag--Al alloy which may also include one or more precious metal elements selected from a group consisting of Ru, Rh, Pd, Os, Ir, Pd and Au. The composite member is formed by introducing the superconductive material into the silver alloy envelope, cross section-reducing the assembly of the envelope and core and, subsequently, thermal treatment for the recovery and setting of the oxygen concentration.
    Type: Grant
    Filed: November 12, 1993
    Date of Patent: February 22, 2000
    Assignee: Vacuumschmelze GmbH
    Inventors: Johannes Tenbrink, Klaus Heine, Paul Puniska, Christine Schmitt